---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "pwCtvau57MoxxR9CnObOcN8u0L+Mca87DI8KSwfBCircigKY/9NaC9UQbR5kuWBMc3+hbuK/1DRyOumDWVgdQvq8Ad9h3iiyx80taxlXGCP+oDh0FAyFpP6av6juksnRRKFRTZfeHxhOOrRVy0Gzk1WXGECPSN14eVzCJWIdLAXfvQ7YM4pf78ByytuYYb010YGJ14gL9fF3nJlf4/lYzKsEoku/ilCaDYO3d8SpPz4/WCfxFR2FuxGHhWuj8/1ml/OQZL6KWjNT+pp8eNdZpaI8tglIbPxj2HREEmTw652QUBNQbb+Ylr0+TkWLEbv5/MS4xLiSxYrNdgPmE+V3kK4q6NNBsYyhcH9kVsq06CA=;Bf4p9jELW2/Dk8TeLt9Vwg=="
---

